Trade ATTO stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Attovia Therapeutics, Inc. (ATTO) is trading at US$22.14, down 2.60% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$895M. Over the past 52 weeks, ATTO has traded between US$16.15 and US$28.00. On Syfe you can trade ATTO with $0 commission and add it to your watchlist.
| Previous close | US$22.73 |
|---|---|
| Market cap | US$895M |
| 52-week range | US$16.15 – US$28.00 |
| Volume | 1.35M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Attovia Therapeutics, Inc.
Attovia Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that creates next-generation biologic medicines for immune-mediated diseases. It was founded in 2022 and is headquartered in San Carlos, CA.
Year: 2026
Attovia Therapeutics, Inc. (ATTO) stock is trading at US$22.14, -2.60% from the previous close of US$22.73.
The market cap for Attovia Therapeutics, Inc. (ATTO) stock is approximately US$895M.
The 52-week high for Attovia Therapeutics, Inc. (ATTO) stock is US$28.00.
The 52-week low for Attovia Therapeutics, Inc. (ATTO) stock is US$16.15.
Attovia Therapeutics, Inc. (ATTO) does not currently pay a dividend.
Stay on top of ATTO
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
